Skip to main content

Prospective Clinical Implementation of CYP2C19-Genotype Guided Antiplatelet Therapy After PCI: a Multi-Site Investigation of MACE Outcomes in a Real-World Setting

Publication ,  Conference
Cavallari, LH; Denny, JC; Lee, CR; Beitelshees, AL; Duarte, JD; Kimmel, SE; Voora, D; McDonough, CW; Gong, Y; Wei, W-Q; Pratt, VM; Coons, JC ...
Published in: CIRCULATION
December 20, 2016

Duke Scholars

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

December 20, 2016

Volume

134

Issue

25

Start / End Page

E711 / E712

Location

New Orleans, LA

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cavallari, L. H., Denny, J. C., Lee, C. R., Beitelshees, A. L., Duarte, J. D., Kimmel, S. E., … Peterson, J. F. (2016). Prospective Clinical Implementation of CYP2C19-Genotype Guided Antiplatelet Therapy After PCI: a Multi-Site Investigation of MACE Outcomes in a Real-World Setting. In CIRCULATION (Vol. 134, pp. E711–E712). New Orleans, LA: LIPPINCOTT WILLIAMS & WILKINS.
Cavallari, Larisa H., Joshua C. Denny, Craig R. Lee, Amber L. Beitelshees, Julio D. Duarte, Steve E. Kimmel, Deepak Voora, et al. “Prospective Clinical Implementation of CYP2C19-Genotype Guided Antiplatelet Therapy After PCI: a Multi-Site Investigation of MACE Outcomes in a Real-World Setting.” In CIRCULATION, 134:E711–12. LIPPINCOTT WILLIAMS & WILKINS, 2016.
Cavallari LH, Denny JC, Lee CR, Beitelshees AL, Duarte JD, Kimmel SE, et al. Prospective Clinical Implementation of CYP2C19-Genotype Guided Antiplatelet Therapy After PCI: a Multi-Site Investigation of MACE Outcomes in a Real-World Setting. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2016. p. E711–2.
Cavallari, Larisa H., et al. “Prospective Clinical Implementation of CYP2C19-Genotype Guided Antiplatelet Therapy After PCI: a Multi-Site Investigation of MACE Outcomes in a Real-World Setting.” CIRCULATION, vol. 134, no. 25, LIPPINCOTT WILLIAMS & WILKINS, 2016, pp. E711–12.
Cavallari LH, Denny JC, Lee CR, Beitelshees AL, Duarte JD, Kimmel SE, Voora D, McDonough CW, Gong Y, Wei W-Q, Pratt VM, Chumnumwat S, Coons JC, Cooper-DeHoff RM, Dave CV, Dillon C, Hamadeh IS, Hines L, Howell LA, Jeng LJ, Lee YM, Skaar TC, Sriramoju VB, Stevenson JM, Vesely MR, Wake D, Kreutz RP, Stouffer GA, Wilke RA, Empey PE, Limdi NA, Roden DM, Shuldiner AR, Johnson JA, Peterson JF. Prospective Clinical Implementation of CYP2C19-Genotype Guided Antiplatelet Therapy After PCI: a Multi-Site Investigation of MACE Outcomes in a Real-World Setting. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2016. p. E711–E712.

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

December 20, 2016

Volume

134

Issue

25

Start / End Page

E711 / E712

Location

New Orleans, LA

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology